METTL7A
Title: Mettl7a: A Crucial Regulator in Gene Expression with Implications in Cancer and Neurological Disorders
Description:
Mettl7a is an enzyme that plays a vital role in RNA metabolism by adding a methyl group to specific adenosine residues in messenger RNA (mRNA). This modification influences gene expression, impacting a wide range of cellular processes. Mettl7a dysregulation has been linked to several diseases, including cancer and neurological disorders.
Associated Diseases:
- Cancer: Mettl7a overexpression has been observed in various cancer types, including leukemia, lung cancer, and breast cancer. It contributes to tumor progression by promoting cell proliferation, invasion, and metastasis.
- Neurological disorders: Mettl7a deficiency has been associated with neurological diseases such as autism spectrum disorder (ASD), intellectual disability, and amyotrophic lateral sclerosis (ALS).
Did you Know ?
- In a study of patients with acute myeloid leukemia (AML), high Mettl7a expression was linked to a 50% higher risk of relapse and a 30% lower overall survival rate.
